Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can closing your eyes help you walk better? new rehab trial for nerve disorder

NCT ID NCT03881930

Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether balance rehabilitation that changes how patients see (closing eyes, using a mask, or projecting moving dots) can improve walking stability better than standard rehab with eyes open. It includes 40 adults with chronic nerve damage who have trouble with balance. Participants will do 20 rehab sessions, and their walking will be measured right after and two months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
balance rehabilitation with modified visual input (eyes closed, mask, or moving dots)
What this could lead to
If it works, this could point toward a better way to improve balance and walking stability in people with nerve damage.
What could go wrong
This is a small, early-stage study with only 40 participants, so results may not apply to everyone. The intervention is non-drug and may not produce lasting benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2019

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with chronic demyelinating acquired neuropathy * Age ≥ 18 years. * Patients able to walk 20 meters without human assistance at least indoors with or without technical assistance. * Patients with complaints such as discomfort, walking instability related to sensitivity disorders. * Patients being clinically stable for at least 2 months, regardless of ongoing treatments. * Patients who have provided consent. Exclusion Criteria: * Patients unable to walk 20 metres without technical and human assistance indoors. * Patients with an ongoing hospitalization. * Patients already included and participating in another intervention study. * Patients with ongoing balance rehabilitation and continued during the REQ-PRO program in another rehabilitation centre or practice. * Patients with ongoing acute treatment (related to polyneuropathy) started less than 2 months ago or stopped less than 2 months ago. * Patients with scheduled surgery during the period of the patient's participation in the protocol, preventing the successful completion of the rehabilitation program and participation in assessments. * Patients with recent surgery, in particular lower limb prosthesis (less than 1 year old) or equipment contraindicated for planned exercises such as standing kneeling positions. * Patients with skin wounds on the foot that contraindicate rehabilitation. * Patients with balance disorders of vestibular origin or central neurological pathology. * Patients with a visual disability. * Patients with a hearing impairment that prevents the patient from hearing and understanding instructions during the rehabilitation program or assessments. * Patients with an inability to speak or understand the French language. * Patients with cognitive or language impairments that prevent understanding of the protocol. * Patients with a residence outside of the Paris Region (Ile de France). * Patients with a known pregnancy. * Patients not affiliated to a social security system (beneficiary or having a right), deprived of their right, under guardianship, curatorship, prisoner.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acquired chronic demyelinating neuropathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Ataxia cerebellar ataxia chronic inflammatory demyelinating polyradiculoneuropathy peripheral nervous system disorder peripheral neuropathy Somatosensory Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ataxia Balance; distorted Neuropathy Proprioceptive disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Service de Médecine Physique et de Réadaptation (MPR)

    RECRUITING

    Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.